Hans van Houte
Director of Finance/CFO at NURIX THERAPEUTICS, INC.
Net worth: 1 M $ as of 30/03/2024
Hans van Houte active positions
Companies | Position | Start | End |
---|---|---|---|
NURIX THERAPEUTICS, INC. | Director of Finance/CFO | 29/02/2016 | - |
Career history of Hans van Houte
Former positions of Hans van Houte
Companies | Position | Start | End |
---|---|---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Director of Finance/CFO | 31/12/2010 | - |
Bionation LLC | Corporate Officer/Principal | - | - |
VERTEX PHARMACEUTICALS INCORPORATED | Comptroller/Controller/Auditor | - | - |
Treasurer | - | - |
Training of Hans van Houte
Babson College | Undergraduate Degree |
Statistics
International
United States | 7 |
Operational
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Comptroller/Controller/Auditor | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
NURIX THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
Bionation LLC |
- Stock Market
- Insiders
- Hans van Houte
- Experience